Hexose-6-phosphate dehydrogenase: A new risk gene for multiple sclerosis

European Journal of Human Genetics

Volumn 18, Issue 5, 2010, Pages 618-620

  Alcina, Antonio ^a   Ramagopalan, Sreeram V ^b   Fernández, Óscar ^c   Catalá Rabasa, Antonio ^a   Fedetz, María ^a   Ndagire, Dorothy ^a   Leyva, Laura ^c   Arnal, Carmen ^d   Delgado, Concepción ^e   Lucas, Miguel ^f   Izquierdo, Guillermo ^f   Ebers, George C ^b   Matesanz, Fuencisla ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e Centro Regional de Transfusión Sanguínea Granada Almería   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

1p36.22; Association; Genetics; H6PD gene; Multiple sclerosis (MS); Polymorphisms

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; KINESIN; LEUCINE; PROLINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CAUCASIAN; CHROMOSOME 1P; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

ADULT; CANADA; CARBOHYDRATE DEHYDROGENASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GREAT BRITAIN; HUMANS; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SPAIN;

EID: 77951620176     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.213     Document Type: Article

References (20)

1. Hauser SL, Oksenberg JR: The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61-76.
2. McElroy JP, Oksenberg JR: Multiple sclerosis genetics. Curr Top Microbiol Immunol 2008; 318: 45-72.
3. Ramagopalan SV, Knight JC, Ebers GC: Multiple sclerosis and the major histocompati-bility complex. Curr Opin Neurol 2009; 22: 219-225.
4. Matesanz F, Caro-Maldonado A, Fedetz M et al: IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. J Neurol 2007; 254: 682-684.
5. International Multiple Sclerosis Genetics Consortium: Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.
6. Gregory SG, Schmidt S, Seth P et al: Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39: 1083-1091.
7. Lundmark F, Duvefelt K, Iacobaeus E et al: Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007; 39: 1108-1113.
8. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV et al: Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 2008; 40: 1402-1403.
9. Kristjansdottir G, Sandling JK, Bonetti A et al: Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008; 45: 362-369.
10. Hoppenbrouwers IA, Aulchenko YS, Ebers GC et al: EVI5 is a risk gene for multiple sclerosis. Genes Immun 2008; 9: 334-337.
11. Hafler JP, Maier LM, Cooper JD et al: CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009; 10: 5-10.
12. International Multiple Sclerosis Genetics Consortium (IMSGC): The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 2009; 10: 11-14.
13. Wellcome Trust Case Control Consortium: Association scan of 14 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329-1337.
14. Ban M, Goris A, Lorentzen AR et al: Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur J Hum Genet 2009; 17: 1309-1313.
15. Poser CM, Paty DW, Scheinberg L et al: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
16. Sadovnick AD, Risch NJ, Ebers GC: Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 1998; 25: 216-221.
17. Lyons DA, Naylor SG, Scholze A, Talbot WS: Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons. Nat Genet 2009; 41: 854-858.
18. Kletzien RF, Harris PKV, Foellmi LA: Glucose-6-phosphate dehydrogenase: a housekeeping enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J 1994; 8: 174-181.
19. Vaughn AE, Deshmukh M: Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome C. Nat Cell Biol 2008; 10: 1477-1483.
20. Draper N, Walker EA, Bujalska IJ et al: Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 2003; 34: 434-439.